Pfizer (PFE) PT Hiked to $62 at Truist Securities, "See Guidance as Conservative"
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas raised the price target on Pfizer (NYSE: PFE) to $62.00 (from $58.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
